Mapping the 'Sweet Brain' in Healthy Participants

Sponsor

University of Manchester (Other)

Overall Status

Completed

CT.gov ID

NCT04162457

Collaborator

Cargill (Industry)

Enrollment

Location

Arms

16.5

Actual Duration (Months)

1.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The human brain has a central role in regulating appetite and food intake. It integrates many metabolic, hedonic and trait-related signals that affect eating behaviour and determine when and how much we eat. The effects of non-nutritive sweeteners (NNS) that provide sweet taste with no calories on appetite, food intake thus weight status remain a subject of debate. In this study, the investigators aim to investigate whole brain response to the ingestion of beverages sweetened with caloric sugars (glucose, maltodextrin) or NNS (stevia) as well as neural substrates of attentional bias to food (pre-and post consumption) in healthy lean participants.

Condition or Disease	Intervention/Treatment	Phase
Obesity Sweeteners	Dietary Supplement: Stevia Dietary Supplement: Glucose Dietary Supplement: Maltodextrin Dietary Supplement: Water	N/A

Detailed Description

Non-nutritive sweeteners (NNS) are zero or no calorie alternatives to caloric sugars and their role in appetite and weight status remains inconclusive. NNS similarly as caloric sweeteners activate the oral sweetness receptors and conscious perception of sweetness. However caloric sugars and NNS differ in their metabolic fate after ingestion, so that caloric sugars lead to raised blood glucose, insulin and satiety inducing gut-peptide levels after meals, but NNS do not influence postprandial metabolism. A recently proposed model suggests that metabolic signals may have indirect effects on food reward processing via alterations in higher cognitive function such as attention (Higgs et al. 2017), the role of sweetness in this model is yet to be examined.

In the proposed study stevia-sweetened beverage will be used as the NNS, glucose-sweetened beverage as the caloric sweetener, water as a non-sweet non-caloric control and maltodextrin as a non-sweet caloric control. The study has two aims: first to investigate whole brain responses following the oral consumption of caloric sugars versus NNS using and physiological MRI, and second to examine the neural correlates of the attentional bias to food cues following the consumption of caloric sugars- vs. NNS-sweetened beverages using task-based functional Magnetic Resonance Imaging (fMRI).

In this study participants will be asked to come to the imaging facility on four separate occasions, corresponding to the four study beverages, glucose, stevia, maltodextrin and water. Before coming to an imaging session participants should consume a breakfast of their preference at home (which will be repeated before each session) and then fast for 3-4 hours. Upon arrival subjects will fill in their mood ratings, and the breakfast composition questionnaire and will be ready to start. Firstly, neural responses will be measured (before consumption of the study beverages) while subjects perform a food visual dot probe task (VPT) previously validated to show differences in attentional bias to food between fasted and fed states (Stamataki et al. 2019). Secondly, a physiological MRI measurement will be performed (Little et al. 2013) which will last 40 minutes. Third, subjects will perform again the VPT (after the consumption of the study beverage) whilst an fMRI measurement will be performed.

Study Design

Study Type:

Interventional

Actual Enrollment :

18 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Intervention Model Description:

Counter-balanced, double-blind, crossover, within-subject design.Counter-balanced, double-blind, crossover, within-subject design.

Masking:

Triple (Participant, Investigator, Outcomes Assessor)

Masking Description:

This study is double blind. All participants are completing 4 testing sessions in randomised and counterbalanced order. Participants and researchers (who are also outcome assessors) are blinded to the beverages content. Un-blinding will be performed following analysis of results

Primary Purpose:

Basic Science

Official Title:

Effects of Caloric and Non-caloric Sweet Preloads on Neural Correlates of Physiological and Neurocognitive Responses in Healthy Participants

Actual Study Start Date :

Nov 14, 2019

Actual Primary Completion Date :

Mar 31, 2021

Actual Study Completion Date :

Mar 31, 2021

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Stevia beverage Participants receive 4 study beverages in the 4 imaging sessions in randomised and counterbalanced order.	Dietary Supplement: Stevia Participants will be administered one of the study beverages at each one of the 4 imaging sessions.
Experimental: Glucose beverage 330 ml of water with glucose (equal sweetness with the stevia beverage)	Dietary Supplement: Glucose Participants will be administered one of the study beverages at each one of the 4 imaging sessions.
Experimental: Maltodextrin beverage 330 ml of water with maltodextrin (equal amount of calories as the glucose beverage)	Dietary Supplement: Maltodextrin Participants will be administered one of the study beverages at each one of the 4 imaging sessions.
Placebo Comparator: Water 330 ml water	Dietary Supplement: Water Participants will be administered one of the study beverages at each one of the 4 imaging sessions.

Outcome Measures

Primary Outcome Measures

physMRI whole brain responses to stevia, glucose and maltodextrin [-10 minutes to 30 minutes post consumption]
Participants will undergo a physiological MRI, which will include 10 minutes of baseline (resting), 10 minutes of drinking the solution, and 20 minutes post-consumption (resting).
fMRI brain response while performing a food visual dot probe task (VPT) [10 minutes (twice)]
Before and 30 minutes after the consumption of the study beverage, participants will perform a food VPT which is designed to assess attentional bias to food cues while an fMRI will be conducted. Subjects neural activation when they are responding to congruent trials (dot appearing on the position of a food picture) compared to incongruent trials (dot appearing on the position of a neutral picture).

Secondary Outcome Measures

Attentional bias to food cues (behavioral) [pre- and post (30 minutes) consumption of the study beverage]
Reaction times to congruent and incongruent trials will be recorded, and an attentional bias to food cues score will be calculated and expressed as the difference pre-and post consumption across the 4 experimental conditions.
Appetite ratings [-10 minutes (before consumption) to 30 minutes post-consumption]
Participant will be asked to rate their subjective appetite (hunger, fullness) at regular intervals during the physMRI. The mean ratings over time, change from baseline as well as area under the curve will be assessed. Scale includes 0-10 values where 0 is not at all (i.e. not hungry at all) and 10 is extremely (i.e. extremely hungry)
Sweetness ratings [at 10 minutes postprandially]
Following the consumption of the beverages participants will be asked to rate the sweetness of the beverage they consumed. Scale includes 0-10 values where 0 is not at all (i.e. not sweet at all) and 10 is extremely (i.e. extremely sweet)

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 40 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Age 18 - 40 years
BMI between 18.5-25 kg/m2
Registered to a GP
Non-restrained eaters, restraint eating score on the Dutch Eating Behaviour Questionnaire (DEBQ) ≤ 3
Healthy - general good health
Currently not taking any medication (other than females taking the oral contraceptives or over the counter medication such as paracetamol)
Normal or corrected vision
Right-handedness (including left-handers could bias the results because of the laterality of brain functions)
Regular breakfast eaters (≥5 times per week)
Stable weight, ± 5 kg last 3 months
No self-reported food allergy or intolerance to foods supplied during the study
No or low NNS consumers (up to 1 can of diet soda per week or 1 sachet of NNS per week)
Willing to comply with the study protocol
Willingness to be informed about chance findings of pathology
The participant is capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.
The participant is able to read, comprehend and record information written in English.
A signed and dated written informed consent is obtained from the participant.

Exclusion Criteria:

Habitual NNS consumers, >1 can of diet beverage or >1 table packet of sweeteners per week
Subjects who have a non-removable metal object in or at their body, such as, for example: heart pace-maker, artificial heart valve, metal prosthesis, implants or splinters, non-removable dental braces
Tattoos, that are older than 15 years
Claustrophobia
Pathological hearing ability or an increased sensitivity to loud noises
Operation less than 3 months ago
Acute illness or infection during the last 4 weeks
Moderate or severe head injury
Any metabolic (e.g. metabolic disorder, diabetes, insulin resistance), psychological (e.g. depression), gastrointestinal or neurological (e.g. epilepsy, headache disorder, multiple sclerosis, traumatic brain injuries) diseases or medication in relation to these diseases.
Currently experiencing anxiety or depression
Use of recreational substances in the last month
Age under 18 years or over 40 years old.
BMI >25 kg/m2 and <18.5 kg/m2
Restrained eaters (DEBQ for restraint eating ≥ 3)
Current weight loss regimens, or more than 5 kg weight loss/gain in the last 3 months
Subjects who follow special diets for weight maintenance, such as Atkins Diet, Weight Watchers, gluten-free diet, The Zone diet, Vegetarian Diet, Raw Food Diet etc.
Subjects having breakfast less than 5 times per week.
Eating disorders (binge eating disorder, bulimia etc)
Current or past history of drug or alcohol dependency - alcohol consumption exceeding 14 units a week
Female participants who are, or may be, pregnant, or currently lactating.
Subjects who regularly consume dietary supplements for weight loss, muscle building etc.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Manchester	Manchester		United Kingdom	M13 9PG

Sponsors and Collaborators

University of Manchester
Cargill

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:

Nikoleta Stamataki, Chief Investigator, University of Manchester

ClinicalTrials.gov Identifier:

NCT04162457

Other Study ID Numbers:

6814

First Posted:

Nov 14, 2019

Last Update Posted:

Jul 13, 2021

Last Verified:

Jul 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Jul 13, 2021